Product News

Share this article:

Wyeth received FDA approval for a new indication on Tygacil, a pneumonia drug. The additional indication was approved for adult patients with community-acquired bacterial pneumonia.

 

A New York federal judge has asked the FDA to make Plan B, an emergency contraceptive, available to 17-year-olds within 30 days. US District Judge Edward Korman also asked the agency to review whether to make the product available for girls of all ages, without a prescription. Plan B is manufactured by Barr Pharmaceuticals, a division of Teva Pharmaceuticals.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.